NCT04695327 2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1 Completed
Clinical Trials
6 trialsNCT06215846 2025-11-26
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1 Enrolling by invitation
NCT00031083 2020-11-17
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Biogen
Phase 1 Completed
NCT02654938 2017-09-20
Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer
Panacela Labs LLC
Phase 1 Completed
NCT00625430 2011-07-11
FP253-GDEPT
Biotech Equity Partners Pty Ltd
Phase 1 Unknown
NCT00109655 2008-10-03
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
Cell Genesys
Phase 1 Unknown